In Development
News Releases ::
-
Isotechnika announces first sale of commercial supply of voclosporin
-
Isotechnika selected to present at international transplantation conference
-
Isotechnika hires advisors to advance strategic alternatives
Media Coverage ::
-
Isotechnika reports positive Phase 2b trial of voclosporin kidney-transplant drug
-
Voclosporin reduces plaques, has fewer side effects than cyclosporine
-
Voclosporin (ISA247) psoriasis trial shows impressive results
Publications
Isotechnika's Scientific abstracts are available in a consolidated PDF file.
Scientific Abstracts July 2007 (FILE 12.58 MB)
Last updated July 5, 2007